SCFA Alterations in IBS Subtypes: Systematic Evidence and Future Prospects for Biomarker-Based Diagnosis in India

Sanika Limaye, Prajkta Bhide, Anup Kale, Neha Bokey · 2026

Read SCFA Alterations in IBS Subtypes: Systematic Evidence and Future Prospects for Biomarker-Based Diagnosis in India by Sanika Limaye, Prajkta Bhide, Anup Kale, Neha Bokey (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13655589.txt.

Description

Sanika Limaye and co-authors review how gut microbe products differ across irritable bowel syndrome subtypes, with an eye to diagnosis in India. Published in 2026, the systematic review gathers studies that measured fecal short chain fatty acids in patients and healthy controls. Three of these acids, made when microbes ferment fiber, are the focus: propionate, acetate, and butyrate.

Eleven studies qualified. Propionate ran high in patients overall, and most clearly in the diarrhea prone subtype. Total levels dropped in the constipation prone subtype, while acetate and butyrate showed no firm split. Study quality was graded with a standard scale. The authors argue the pattern could seed a biomarker test, tuned to Indian cohorts.

Catalog record

CREATORSanika Limaye, Prajkta Bhide, Anup Kale, Neha Bokey
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE25 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13655589

Browse the full library · About the Tower of Babel